PESSINA, ACHILLE CESARE
 Distribuzione geografica
Continente #
NA - Nord America 20.616
EU - Europa 4.247
AS - Asia 3.237
SA - Sud America 62
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 7
Totale 28.201
Nazione #
US - Stati Uniti d'America 20.584
IT - Italia 1.668
SG - Singapore 1.628
CN - Cina 1.176
FI - Finlandia 616
DE - Germania 488
SE - Svezia 436
UA - Ucraina 353
FR - Francia 231
VN - Vietnam 223
GB - Regno Unito 160
RU - Federazione Russa 148
HK - Hong Kong 98
IN - India 81
BR - Brasile 58
IE - Irlanda 43
CA - Canada 24
RO - Romania 24
NL - Olanda 19
AT - Austria 15
EU - Europa 15
CI - Costa d'Avorio 11
JP - Giappone 7
MX - Messico 7
CH - Svizzera 6
ES - Italia 6
LT - Lituania 6
TR - Turchia 6
GR - Grecia 5
PL - Polonia 5
AU - Australia 4
CZ - Repubblica Ceca 4
BE - Belgio 3
BG - Bulgaria 3
IQ - Iraq 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
AZ - Azerbaigian 2
KE - Kenya 2
AL - Albania 1
AO - Angola 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
EG - Egitto 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
IR - Iran 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
ME - Montenegro 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
SC - Seychelles 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 28.201
Città #
Fairfield 2.700
Jacksonville 2.006
Woodbridge 1.870
Chandler 1.757
Houston 1.476
Ann Arbor 1.464
Ashburn 1.207
Wilmington 1.199
Seattle 965
Cambridge 873
Singapore 775
Princeton 666
Boardman 565
Santa Clara 364
San Diego 301
Beijing 282
Roxbury 275
Nanjing 257
Helsinki 228
Dong Ket 223
Des Moines 196
Medford 173
Milan 156
Hong Kong 98
Rome 90
Nanchang 81
Shenyang 75
Guangzhou 65
Padova 65
Jiaxing 61
New York 60
Norwalk 58
Hebei 56
Changsha 55
London 47
Naples 47
Tianjin 45
Dublin 40
Ogden 38
Redwood City 34
Bologna 24
Turin 24
Florence 23
Los Angeles 21
Horia 20
Verona 20
Palermo 18
Rio Saliceto 15
Falls Church 14
Kharkiv 14
Jinan 13
Kilburn 13
Borås 12
Catania 12
Indiana 12
Munich 12
Napoli 12
Pisa 12
Abidjan 11
Nuremberg 11
Portsmouth 11
Rockville 11
Bolzano 10
Toronto 10
Zhengzhou 10
Brescia 9
Dallas 9
Genoa 9
Shanghai 9
Torino 9
Torre del Greco 9
Trieste 9
Ancona 8
Falkenstein 8
Lauterbourg 8
Pavia 8
Perugia 8
Venezia 8
Vicenza 8
Mantova 7
Redmond 7
Mestre 6
Pescara 6
Prato 6
Rimini 6
Vicopisano 6
Washington 6
Aosta 5
Chennai 5
Deiva Marina 5
Detroit 5
Kolkata 5
Livorno 5
Parma 5
Southwark 5
Treviso 5
Varese 5
Vienna 5
Alba 4
Amsterdam 4
Totale 21.590
Nome #
Rapporto aldosterone /renina (ARR) calcolato mediante attività reninica plasmatica o renina diretta della diagnosi dell'aldosteronoma (APA). 1.634
Adrenocorticotropic Hormone Stimulation During Adrenal Vein Sampling for Identifying Surgically Curable Subtypes of Primary Aldosteronism Comparison of 3 Different Protocols 153
PROGNOSTIC VALUE OF NEPHROGRAPHY IN ATHEROSCLEROTIC OCCLUSION OF THE RENAL ARTERY. 142
Menopause does not affect blood pressure and risk profile, and menopausal women do not become similar to men. 142
Serum uric acid shows a J-shaped trend with coronary mortality in non-insulin-dependent diabetic elderly people. The CArdiovascular STudy in the ELderly (CASTEL). 142
Sistema renina angiotensina ed endotelina (ET)-1 nella regolazione della fibrosi renale tubulare, glomerulare e vascolare. 133
Autocrine-paracrine role of endothelin-1 in the regulation of aldosterone synthase expression and intracellular Ca2+ in human adrenocortical carcinoma NCI-H295 cells. 131
Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's Syndrome with an ominous clinical course 122
Effects of canrenoate on red cell sodium transport and calf flow in essential hypertension. 117
Measurement of endothelin: clinical and research use 116
Isomyosin distribution in normal and pressure overloaded rat ventricular myocardium. An immunohistochemical study 115
Computer analysis of continuous direct blood pressure recording. 115
Blood pressure and metabolic profile after surgical menopause: comparison with fertile and naturally-menopausal women 115
The white-coat effect is unrelated to the difference between clinic and daytime blood pressure and is associated with greater reactivity to public speaking 114
Systolic and diastolic short-term blood pressure variability and its determinants in patients with controlled and uncontrolled hypertension: A retrospective cohort study 112
THE 24-HOUR RHYTHM OF BLOOD PRESSURE DIFFERS FROM THAT OF LEG HEMODYNAMICS IN ORTHOTOPIC HEART TRANSPLANT RECIPIENTS 112
Short-term effects of metformin on insulin sensitivity and sodium homeostasis in essential hypertensives. 112
Myocardial perfusion defects in Bartter and Gitelman syndromes 111
Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women. 111
Endothelin-1 and Its mRNA in the wall layers of human arteries ex vivo 111
A STRESS REACTION AFFECTS ASSESSMENT OF SELECTIVITY OF ADRENAL VENOUS SAMPLING AND OF LATERALIZATION OF ALDOSTERONE EXCESS IN PRIMARY ALDOSTERONISM. 111
Effects of captopril on renal function in hypertensive patients. 109
Blockade of angiotensin II type 1 receptor and not of endothelin receptor prevents hypertension and cardiovascular disease in transgenic (mREN2)27 rats via adrenocortical steroid-independent mechanisms 108
Effect of olmesartan medoxomil on number and survival of circulating endothelial progenitor cells and calcitonin gene related peptide in hypertensive patients. 108
Weak effect of hypertension and other classic risk factors in the elderly who have already paid their toll. 107
Under treatment with lipid-lowering drugs of high-risk coronary heart disease patients of the GENICA study 107
Pulse hypertension: a new component of the metabolic syndrome in elderly women? 107
Continuous ambulatory blood pressure monitoring versus casual blood pressure in borderline hypertension. 106
Red blood cell Li+/Na+ exchange in patients with diabetic nephropathy and essential hypertension: therapeutic implications. 105
Population-based studies improve outcome in hypertensive patients. 104
A role for heme oxygenase-1 in the antioxidant and antiapoptotic effects of erythropoietin: The start of a good news/bad news story? 103
Body Mass Index Predicts Plasma Aldosterone Concentrations in Overweight-ObesePrimary Hypertensive Patients 102
Molecular mechanisms of aldosterone excess in aldosterone-producing adenoma revealed by DNA microarray analysis. 101
Tissue kallikrein gene polymorphisms induce no change in endothelium-dependent or independent vasodilation in hypertensive and normotensive subjects 101
Blood pressure variability in 'labile' and 'established' hypertension. 101
German origin clusters for high cardiovascular risk in an Italian enclave 101
Skinfold thickness and blood pressure across C-344T polymorphism of CYP11B2 gene. 101
The natural history of hypertension in turkeys. 101
Endothelin receptor blockade lowers plasma aldosterone levels via different mechanisms in primary aldosteronism and high-to-normal renin hypertension 100
Association between the -514 C to T polymorphism of the hepatic lipase gene promoter and unstable carotid plaque in patients with severe carotid artery stenosis 100
Subtyping of Primary Aldosteronism in the AVIS-2 Study: Assessment of Selectivity and Lateralization 100
The aldosterone renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma. 99
Red blood cell Na+/H+ and Li+/Na+ exchange in patients with essential hypertension. 99
24 h rhythm of blood pressure and forearm peripheral resistance in normotensive and hypertensive subjects confined to bed. 99
Molecular mechanisms of aldosterone excess in aldosterone-producing adenoma revealed by oligomicroarray analysis. 98
Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension 98
Relationship of early carotid artery disease with lipoprotein (a), apolipoprotein B, and fibrinogen in asymptomatic essential hypertensive patients and normotensive subjects 98
Arterial hypertension and mortality in the elderly 98
C-344T POLYMORPHISM OF THE ALDOSTERONE SYNTHASE GENE AND BLOOD PRESSURE IN THE ELDERLY: A POPULATION BASED STUDY 97
Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients 97
PULSE PRESSURE AND CORONARY MORTALITY IN ELDERLY MEN AND WOMEN FROM GENERAL POPULATION 96
Insulin generates free radicals in human fibroblasts ex vivo by a protein kinase C-dependent mechanism, which is inhibited by pravastatin 96
Role of angiotensin II, endothelin-1 and L-type calcium channel in the development of glomerular, tubulointerstitial and perivascular fibrosis 96
Percutaneous transluminal renal angioplasty: influence of complications on long-term blood pressure results. 95
Whole transcriptome analysis of aldosterone-producing adenomas reveals the genes underlying responsiveness to ACTH. 61st Annual High Blood Pressure Research Conference 2007, September 28, 2007, Tucson, AZ. Hypertension 207; 50: e129 95
Dynamic testing during adrenal vein sampling for the diagnosis of Conn's adenoma 95
Adiponectin receptor expression in the human adrenal cortex and aldosterone-producing adenomas 95
24-hour leg and forearm haemodynamics in transected spinal cord subjects. 95
In vitro vascular reactivity to endothelin: a comparison between young and old normotensive and hypertensive rats. 94
Intravenous thrombolysis in the emergency department for the treatment of acute ischaemic stroke 94
Is homocysteine important as risk factor for coronary heart disease? 94
Association between coffee consumption and risk of hypertension 94
Pulse pressure: an independent predictor of coronary and stroke mortality in elderly females from the general population. 94
Effects of the C825T polymorphism of the GNB3 gene on body adiposity and blood pressure in fertile and menopausal women: a population-based study. 93
Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism. 93
Comparison of methods for determination ofglomerular filtration rate in hypertensive subjects with normal serum creatinine 93
The T-786 C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in caucasian patients of the GENICA study 92
Perindopril versus captopril: efficacy and acceptability in an Italian multicenter trial. 92
Abnormal regulation of G protein alpha(i2) subunit in skin fibroblasts from insulin-resistant hypertensive individuals 91
Aldosterone and refractory hypertension: A prospective cohort study 91
Plasma adiponectin for prediction of cardiovascular events and mortality in high-risk patients 91
Hyperhomocysteinemia is inversely related with left ventricular ejection fraction and predicts cardiovascular mortality in high-risk coronary artery disease hypertensives 91
THE ALDOSTERONE RENIN RATIO BASED ON THE PLASMA RENIN ACTIVITY AND THE DIRECT RENIN ASSAY FOR DIAGNOSING ALDOSTERONE-PRODUCING ADENOMA 91
Homocysteine, left ventricular dysfunction and coronary artery disease: is there a link? 91
Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism. 91
The 24-hour rhythm of blood pressure differs from that of leg hemodynamics in orthotopic heart transplant recipients. 91
Abnormal erythrocyte and renal frusemide-sensitive sodium transport in idiopathic calcium nephrolithiasis. 91
Electrocardiographic criteria of left ventricular hypertrophy in general population 90
The T-786 C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of caucasian hypertensive patients 90
Reversible renal failure. 90
Chromogranin A Measurement For assessing The Selectivity of Adrenal Venous Sampling in Primary Aldosteronism 89
Comparative effects of the dual ACE-NEP inhibitor MDL-100,240 and ramipril on hypertension and cardiovascular disease in endogenous angiotensin II-dependent hypertension 89
Heterogeneity of aldosterone producing adenomas revealed by gene expression profiling with DNA microarray analysis. 89
Aldosterone secretion in patients treated with simvastatin and ACE inhibitors. 89
Primary aldosteronism: an update on screening, diagnosis and treatment 87
Dual ACE and NEP inhibitor MDL-100,240 prevents and regresses severe angiotensin-II-dependent hypertension partially through bradykinin type 2 receptor 87
The T-786C endothelial nitric oxide synthase genotype and coronary artery disease - Reply 87
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. 87
IS MENOPAUSE AN INDEPENDENT CARDIOVASCULAR RISK FACTOR? EVIDENCES FROM CORSS-SECTIONAL AND LONGITUDINAL POPULATION-BASED STUDIES. 86
Cardiac fibrosis in Tg(mREN2)rats (TGR) involves both AT-1 and endothelin receptors. 86
TOTAL CHOLESTEROL AND MORTALITY IN THE ELDERLY 86
Chromogranin A Measurement for Assessing the Selectivity of Adrenal Venous Sampling in Primary Aldosteronism 86
A thoracic mass with hypertension and hypokalaemia 86
Haemodynamic effects of coffee and caffeine in normal volunteers: a placebo-controlled clinical study. 86
Aortic smooth muscle cell phenotypic modulation and fibrillar collagen deposition in angiotensin II-dependent hypertension. 85
[Arterial hypertension and the renin-angiotensin-aldosterone system in psoriasis] 84
Comparison of three different protocols of ACTH stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism. 84
Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension 84
Low-denisty lipoprotein cholesterol and mortality in older people 84
Adrenal vein sampling for identification of surgically curable primary aldosteronism: impact of accessory hepatic veins on the selectivity index. 84
Totale 11.536
Categoria #
all - tutte 101.399
article - articoli 90.078
book - libri 515
conference - conferenze 0
curatela - curatele 0
other - altro 187
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.162
Totale 194.341


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.642 0 0 0 0 0 0 0 0 431 541 363 307
2020/20213.658 147 305 131 308 143 450 122 357 547 259 448 441
2021/20224.254 67 601 364 419 178 305 102 475 219 75 452 997
2022/20233.791 805 336 113 389 672 519 26 231 411 53 156 80
2023/20241.845 118 243 196 157 135 157 82 109 98 64 249 237
2024/20253.729 71 560 323 272 1.051 129 291 461 571 0 0 0
Totale 28.288